DOSTINEX 0,5MG TBL NOB 2 II ( KABERGOLIN )

Indications
menstrual irregularities
female infertility
to suppress lactation (after childbirth or abortion)
pituitary tumors.
Use during pregnancy and lactation
Pregnancy should be avoided for at least 1 month after discontinuation of Dostinex treatment, as it has a long half-life, and there are only limited data on the effect of the drug on the fetus, although the use of Dostinex 0.5-2 mg per week for diseases associated with hyperprolactinemia, is not accompanied by an increased risk of miscarriage, premature birth, various pregnancy anomalies and congenital malformations of the fetus.

Buy DOSTINEX

Price DOSTINEX